UTD THERAPEUTIC is a biotechnology company focused on combating cardiovascular, inflammatory, and infectious diseases with unique therapeutic products. These products include pharmaceuticals, arginine products and telemedicine services. United Therapeutics Corp. has a market cap of $2.43 billion; its shares were traded at around $45.8 with a P/E ratio of 54.9 and P/S ratio of 8.7.
UTHR is in the portfolios of Ken Heebner of CAPITAL GROWTH MANAGEMENT LP, Edward Owens of Vanguard Health Care Fund.
Insiders' Positions with UTHR
- Buy:: CEO Martine A Rothblatt bought 24,000 shares of UTHR stock on 06/11/2009 at the average price of 42.2, the price of the stock has increased by 8.53% since
- Buy:: CEO Martine A Rothblatt bought 24,000 shares of UTHR stock on 06/11/2009 at the average price of 40.2, the price of the stock has increased by 13.93% since
- Buy:: CEO Martine A Rothblatt bought 78,028 shares of UTHR stock on 06/11/2009 at the average price of 42.53, the price of the stock has increased by 7.69% since
- Buy:: CEO Martine A Rothblatt bought 71,924 shares of UTHR stock on 06/11/2009 at the average price of 42.25, the price of the stock has increased by 8.4% since
Insiders' Positions with UTHR
- Sell:: CFO John Maxim Ferrari sold 2,000 shares of UTHR stock on 08/05/2009 at the average price of 47.55, the price of the stock has decreased by 3.68% since
- Sell:: CFO John Maxim Ferrari sold 7,494 shares of UTHR stock on 06/04/2009 at the average price of 41.21, the price of the stock has increased by 11.14% since
Insiders' Positions with UTHR
- Sell:: EVP & General Counsel Paul A Mahon sold 8,000 shares of UTHR stock on 11/20/2009 at the average price of 45, the price of the stock has increased by 1.78% since
- Sell:: President & COO Roger Jeffs sold 8,000 shares of UTHR stock on 10/15/2009 at the average price of 45, the price of the stock has increased by 1.78% since
- Sell:: EVP & General Counsel Paul A Mahon sold 4,000 shares of UTHR stock on 10/15/2009 at the average price of 45, the price of the stock has increased by 1.78% since
- Sell:: Director Christopher Causey sold 2,000 shares of UTHR stock on 10/01/2009 at the average price of 48.46, the price of the stock has decreased by 5.49% since
- Sell:: Director Christopher Patusky sold 6,666 shares of UTHR stock on 10/01/2009 at the average price of 48.46, the price of the stock has decreased by 5.49% since
Rate This Article: |
  |